Oculis Holding AG — Financial Statements (NASDAQ:OCS) | MetaTrader

Open full chart

Noticias

Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Acciones de Oculis suben tras designación de terapia innovadora de la FDA

Las acciones de Oculis se disparan tras la designación de terapia innovadora por la FDA

Oculis stock surges after FDA grants breakthrough therapy designation

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday - Aeva Technologies (NASDAQ:AEVA), Albemarle (NYSE:ALB)

Stifel eleva precio objetivo de Oculis a $40 por avances en neuro-oftalmología

Stifel eleva el precio objetivo de las acciones de Oculis a 40 dólares por avances en neuro-oftalmología

Oculis stock price target raised to $40 by Stifel on neuro-ophthalmology progress

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Arthur J. Gallagher (NYSE:AJG), AeroVironment (NASDAQ:AVAV)

Wall Street Analysts Predict a 106.04% Upside in Oculis Holding AG (OCS): Here's What You Should Know

Oculis Holding AG (OCS) Upgraded to Buy: Here's What You Should Know

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Linde (NASDAQ:LIN), Compass Therapeutics (NASDAQ:CMPX)